Consistent with this, Pabst et al. later identified GPR56 as a reliable leukemia stem cell (LSC) biomarker for most primary human AMLs by using next-generation sequencing and in vivo analyses of LSC frequencies. The gene discussed is ADGRG1; the disease is leukemia.